Correlation Between Gloria Material and GeneReach Biotechnology
Can any of the company-specific risk be diversified away by investing in both Gloria Material and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gloria Material and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gloria Material Technology and GeneReach Biotechnology, you can compare the effects of market volatilities on Gloria Material and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gloria Material with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gloria Material and GeneReach Biotechnology.
Diversification Opportunities for Gloria Material and GeneReach Biotechnology
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Gloria and GeneReach is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Gloria Material Technology and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Gloria Material is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gloria Material Technology are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Gloria Material i.e., Gloria Material and GeneReach Biotechnology go up and down completely randomly.
Pair Corralation between Gloria Material and GeneReach Biotechnology
Assuming the 90 days trading horizon Gloria Material Technology is expected to generate 0.65 times more return on investment than GeneReach Biotechnology. However, Gloria Material Technology is 1.54 times less risky than GeneReach Biotechnology. It trades about 0.23 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.07 per unit of risk. If you would invest 4,630 in Gloria Material Technology on October 30, 2024 and sell it today you would earn a total of 215.00 from holding Gloria Material Technology or generate 4.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gloria Material Technology vs. GeneReach Biotechnology
Performance |
| Timeline |
| Gloria Material Tech |
| GeneReach Biotechnology |
Gloria Material and GeneReach Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gloria Material and GeneReach Biotechnology
The main advantage of trading using opposite Gloria Material and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gloria Material position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.| Gloria Material vs. Thunder Tiger Corp | Gloria Material vs. Synmosa Biopharma | Gloria Material vs. Taiwan Glass Ind | Gloria Material vs. Tong Tai Machine Tool |
| GeneReach Biotechnology vs. Oneness Biotech Co | GeneReach Biotechnology vs. EirGenix | GeneReach Biotechnology vs. Medigen Vaccine Biologics | GeneReach Biotechnology vs. OBI Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |